Kura Oncology Inc (KURA) Stock Forecast & Price Target
Kura Oncology Inc · NASDAQ
$9.30-0.85 (-8.36%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Kura Oncology Inc, 9 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets range widely, $15.00 to $40.00 (about 2.7x), a sign of real disagreement on valuation. The average target of $26.11 sits 181% above the current $9.30. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.89 next quarter toward $-2.58 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Strong Buy
Strong Buy00%
Buy990%
Hold110%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Kura Oncology Inc.
As of Jul, 9 of 10 firms rate KURA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
KURA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.89
Range $-1.06 – $-0.70 · 9 analysts · +5% YoY
Next period, 9 analysts expect Kura Oncology Inc to earn $-0.89 a share (range $-1.06 – $-0.70), versus $-0.85 a year earlier. Full-year consensus is $-3.44, growing to $-2.58 the year after.
REVENUE · NEXT QUARTER
$23.4M
Range $7.0M – $32.0M · 9 analysts · +13% YoY
Revenue is expected to reach $23.4M (range $7.0M – $32.0M), +12.9% year-over-year. Full-year consensus is $95.0M, rising to $214.6M next year.
Top analysts covering Kura Oncology Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KURA.
#1
Li Watsek
Cantor Fitzgerald · Rank #218
Buy
No targeton KURA
Overall win rate
38%
+ Follow
#2
Joseph Pantginis
HC Wainwright & Co. · Rank #266
Buy
$40.00+330.0% to target
Overall win rate
32%
+ Follow
#3
Reni J. Benjamin
JMP Securities · Rank #290
Buy
$24.00+158.0% to target
Overall win rate
33%
+ Follow
#4
Robert Driscoll
Wedbush · Rank #313
Buy
$36.00+287.0% to target
Overall win rate
30%
+ Follow
#5
DD
David Dai
UBS
Buy
$15.00+61.3% to target
Coverage
—
+ Follow
KURA stock forecast FAQ
What is KURA's average 12-month price target?+
The 8 analysts with a live target average $26.11 for Kura Oncology Inc over the next 12 months, ranging from a $40.00 high to a $15.00 low.
Is KURA stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 10 analyst ratings, 9 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for KURA?+
The Street-high target is $40.00 (HC Wainwright & Co.), and the Street-low is $15.00 (UBS). The average of all 8 active targets is $26.11.
How many Wall Street analysts cover KURA?+
10 analysts have an active rating on Kura Oncology Inc, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering KURA?+
Among analysts who currently cover KURA, Li Watsek of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #218). Their current call is Buy.
What is Kura Oncology Inc's projected EPS for next quarter?+
The consensus estimate is $-0.89 per share (range $-1.06 – $-0.70) across 9 analysts. Full-year EPS is projected at $-3.44, rising to $-2.58 the following year.
How much revenue is Kura Oncology Inc expected to report next quarter?+
Consensus revenue is $23.4M (range $7.0M – $32.0M). Full-year revenue is projected at $95.0M, growing to $214.6M next year.
Have analysts been upgrading or downgrading KURA lately?+
As of Jul, 9 of 10 firms rate KURA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KURA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
